Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab.
Hamada Y, Thomas D, McDonald VM, Harvey ES, Fricker M, Gillman A, Hew M, Kritikos V, Upham JW, Gibson PG. Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Ann Allergy Asthma Immunol. 2025 11; 135(5):537-546.e12.